文献速递临床试验与 GCP

针对人格障碍门诊患者的创伤聚焦EMDR治疗(TEMPO):多中心、单盲、随机对照试验研究方案

Trauma-focused EMDR for Personality disorders among Outpatients (TEMPO): study protocol for a multi-centre, single-blind, randomized controlled trial.
PubMed 文献 · Trials · 2022-03-04

该研究为多中心单盲随机对照试验,计划纳入159例人格障碍患者,比较创伤聚焦EMDR治疗(每两周一次、每次90分钟、共10次)与等待名单在降低人格障碍症状严重度方面的效果,并评估创伤症状、诊断丧失、个人功能、生活质量、成本效果及治疗成功预测因素等。

要点

  • EMDR组接受每两周一次、每次90分钟、共10次的创伤聚焦EMDR治疗,对照组为等待名单。
  • 主要结局为DSM-IV人格障碍评估和DSM-5临床医生用PTSD量表。
  • 随访包括基线、干预后及3、6、12个月,评估长期效果与成本效果。

核心结论

  • 预期结果将有助于了解创伤聚焦EMDR治疗对人格障碍患者的有效性和成本效果,随访数据可记录其对多种结局变量的长期影响,最重要的是降低人格障碍症状严重度和诊断丧失。

研究设计与样本

  • 多中心、单盲、随机对照试验,计划纳入159例人格障碍患者,使用DSM-5人格障碍结构化临床访谈确定诊断。
  • 参与者被分配到EMDR治疗组(每两周一次、每次90分钟、共10次)或等待名单组,EMDR治疗后3个月可接受人格障碍的常规治疗。
  • 所有参与者接受单盲的基线、干预后及3、6、12个月随访评估。

主要发现

  • 原文未报告结果,本文为研究方案。

关键数值与推荐

  • 主要结局指标为DSM-IV人格障碍评估和DSM-5临床医生用PTSD量表。
  • 成本效果评估使用精神障碍患者治疗成本清单、EuroQol-5D-3L和精神健康生活质量问卷。
  • 创伤症状严重度使用DSM-5PTSD检查表、简短状态偏执检查表和情绪调节困难量表进一步评估。
  • 基线使用童年创伤问卷简版和DSM-5生活事件检查表识别创伤类型。
  • 个人功能和健康结局使用人格功能水平量表-BF 2.0、结局问卷-45和精神健康生活质量问卷评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Existing recommended treatment options for personality disorders (PDs) are extensive and costly. There is emerging evidence indicating that trauma-focused treatment using eye movement desensitization and reprocessing (EMDR) therapy aimed at resolving memories of individuals' adverse events can be beneficial for this target group within a relatively short time frame. The primary purpose of the present study is to determine the effectiveness of EMDR therapy versus waiting list in reducing PD symptom severity. Furthermore, the effects of EMDR therapy on trauma symptom severity, loss of diagnosis, personal functioning, quality of life, and mental health outcomes will be determined. In addition, the cost-effectiveness of EMDR therapy in the treatment of PDs is investigated. Moreover, predictors of treatment success, symptom deterioration and treatment discontinuation will be assessed. Lastly, experiences with EMDR therapy will be explored. METHOD: In total, 159 patients with a PD will be included in a large multicentre single-blind randomized controlled trial. The Structured Clinical Interview for DSM-5 Personality Disorders will be used to determine the presence of a PD. Participants will be allocated to either a treatment condition with EMDR therapy (ten biweekly 90-min sessions) or a waiting list. Three months after potential treatment with EMDR therapy, patients can receive treatment as usual for their PD. All participants are subject to single-blinded baseline, post-intervention and 3-, 6- and 12-month follow-up assessments. The primary outcome measures are the Assessment of DSM-IV Personality Disorders and the Clinician-Administered PTSD Scale for DSM-5. For cost-effectiveness, the Treatment Inventory of Costs in Patients with psychiatric disorders, EuroQol-5D-3L, and the Mental Health Quality of Life Questionnaire will be administered. The PTSD Checklist for DSM-5, Brief State Paranoia Checklist and Difficulties in Emotion Regulation Scale will be used to further index trauma symptom severity. Type of trauma is identified at baseline with the Childhood Trauma Questionnaire-SF and Life Events Checklist for the DSM-5. Personal functioning and health outcome are assessed with the Level of Personality Functioning Scale-BF 2.0, Outcome Questionnaire-45 and Mental Health Quality of Life Questionnaire. Experiences with EMDR therapy of patients in the EMDR therapy condition are explored with a semi-structured interview at post-intervention. DISCUSSION: It is expected that the results of this study will contribute to knowledge about the effectiveness, and cost-effectiveness of trauma-focused treatment using EMDR therapy in individuals diagnosed with a PD. Follow-up data provide documentation of long-term effects of EMDR therapy on various outcome variables, most importantly the reduction of PD symptom severity and loss of diagnoses. TRIAL REGISTRATION: Netherlands Trial Register NL9078 . Registered on 31 November 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hofman S, Hafkemeijer L, de Jongh A, et al. Trauma-focused EMDR for Personality disorders among Outpatients (TEMPO): study protocol for a multi-centre, single-blind, randomized controlled trial. Trials. 2022. PMID: 35246228. doi:10.1186/s13063-022-06082-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。